Media 02 Aug 2021 Orthocell (ASX:OCC) has breakthrough tissue engineering study published in US Orthocell has been featured in The Market Herald, following the publication of our breakthrough tissue engineering study in the peer-reviewed… Orthocell
Media 13 Jul 2021 Orthocell (ASX:OCC) appoints exclusive distributor for Striate+ Orthocell has been featured in The Market Herald, announcing the appointment of Samson Medical Technologies (SMT) as its exclusive distributor for… Orthocell
Media, Video 27 Jun 2021 Video | Stockhead Investor Presentation – June 2021 Orthocell CEO and Managing Director Paul Anderson spoke with Oriel Morrison as part of Stockhead V-Con Biotechs. Orthocell
Media, Video 22 Jun 2021 Video | Ticker News Interview – June 2021 Orthocell CEO and Managing Director, Paul Anderson, spoke with Ticker News about the positive findings from our CelGro™ clinical study. Orthocell
Media, Video 22 Jun 2021 Video | Proactive Investors – June 2021 Orthocell CEO and Managing Director Paul Anderson discusses with Proactive positive nerve regeneration results one year on from a study… Orthocell
Media 16 Jun 2021 Orthocell (ASX:OCC) secures Chinese and NZ patents Orthocell has been featured in The Market Herald, following our announcement of patents granted in China and New Zealand for… Orthocell
Media, Video 27 May 2021 Video | Proactive Investors – May 2021 Orthocell CEO and Managing Director Paul Anderson speaks to Proactive following the announcement newly granted patents for its CelGro™ collagen… Orthocell
Media 26 May 2021 Orthocell (ASX:OCC) granted new patents for ACL repair treatment Orthocell has been featured in The Market Herald, following our announcement of granted patents in China and Hong Kong for… Orthocell
Media 15 Feb 2021 Orthocell (ASX:OCC) receives new U.S. patent for CelGro Orthocell has been featured in The Market Herald, following the announcement of a newly granted U.S. divisional patent for CelGro.… Orthocell
Media 14 Jan 2021 Orthocell’s stock soars following FDA 510(k) clearance of regenerative collagen medical device BioWorld has reported on Orthocell's rising share price, following the U.S. approval for our collagen medical device for dental guided… Orthocell
